A full text of this article is accessible at:
http://www.sciencedirect.com/science/journal/15071367
New - fast track review!
Dear Authors,If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.
Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak (michal.masternak@ucf.edu) for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).
Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak (michal.masternak@ucf.edu) for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).
Volume 17, Number 2, 2012
The importance of accurate treatment planning, delivery, and dose verification
Julian Malicki
Summary:
In recent years, the spectacular technological advances in radiotherapy have generated much enthusiasm.1 Newer techniques take advantage of increased computing power and real-time imaging to provide pinpoint accuracy and dose conformity.
The most widely adopted of the new techniques is undoubtedly intensity-modulated radiation therapy (IMRT) and variations thereof. Described as “perhaps the most significant technical advances in radiation therapy since the linear accelerator”, IMRT gives us the ability to deliver highly conformal nonconvex dose distributions to the target with astonishing precision.2 Compared to 3D-CRT, IMRT offers many advantages, particular better dose distribution in concave target volumes and lower doses to organs at risk (OAR).3,4 IMRT is surely an immense technological leap forward, though not without certain risks.
Signature: Rep Pract Oncol Radiother, 2012; 17(2)
: 63-65
